Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 90,000 shares at $6.71 ($613K) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Open-market sale of $613k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.95 | 18,585 | $129K | 21.1% |
| 2 | $6.95 | 18,585 | $129K | 21.1% |
| 3 | $6.71 | 26,415 | $177K | 28.9% |
| 4 | $6.71 | 26,415 | $177K | 28.9% |
| Total | $6.81 avg | 90,000 | $613K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |